Patient Voice, • 9/19/25 Leveraging Patient Advocacy To Scale Rare Disease Trials Previous Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Next How To Prevent Failure in Rare Disease Trials? You Might Also Like Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials Case Studies in Rare Disease Commercialization: Lessons Learned Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials Adaptive & Precision-Driven Trials: Platform and MATCH Models for Rare Disease Breakthroughs
Patient Voice, • 9/19/25 Leveraging Patient Advocacy To Scale Rare Disease Trials Previous Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Next How To Prevent Failure in Rare Disease Trials? You Might Also Like Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials Case Studies in Rare Disease Commercialization: Lessons Learned Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials Adaptive & Precision-Driven Trials: Platform and MATCH Models for Rare Disease Breakthroughs
